hey mate, where does it say they only tested 25, 50, 100?
benefits of testing low is if successful means that they dont need as much of the drugbto produce the same result - cheaper to produce the drug then...
looks like they need to test higher (150??) To achieve result as shown by other studies elsewhere in the world. Maybe they were hoping bioavailability of satipharm would help make the drug work at lower doses.
- Forums
- ASX - By Stock
- CAN
- Ann: S3 Trial update
Ann: S3 Trial update, page-31
-
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAN (ASX) to my watchlist
|
|||||
Last
3.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.41M |
Open | High | Low | Value | Volume |
3.4¢ | 3.4¢ | 3.3¢ | $4.901K | 145.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 4278 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.033 |
6 | 1985018 | 0.032 |
7 | 304288 | 0.031 |
11 | 2533334 | 0.030 |
4 | 83112 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 4278 | 1 |
0.036 | 60000 | 3 |
0.037 | 50000 | 1 |
0.038 | 362496 | 2 |
0.039 | 36000 | 3 |
Last trade - 15.59pm 16/08/2024 (20 minute delay) ? |
Featured News
CAN (ASX) Chart |